Incidence of Adverse Events at 3 Months Versus at 12 Months After Dual Antiplatelet Therapy Cessation in Patients Treated With Thin Stents With Unprotected Left Main or Coronary Bifurcations

Fabrizio D'Ascenzo, Umberto Barbero, Mohamed Abdirashid, Daniela Trabattoni, Giacomo Boccuzzi, Nicola Ryan, Giorgio Quadri, Davide Capodanno, Giuseppe Venuti, Saverio Muscoli, Francesco Tomassini, Michele Autelli, Andrea Montabone, Wojciech Wojakowski, Andrea Rognoni, Diego Gallo, Radoslaw Parma, Leonardo De Luca, Filippo Figini, Satoru MitomoAntonio Montefusco, Alessio Mattesini, Wojciech Wańha, Marcin Protasiewicz, Grzegorz Smolka, Zenon Huczek, Cristina Rolfo, Bernardo Cortese, Alaide Chieffo, Wiktor Kuliczowki, Ivan Nuñez-Gil, Umberto Morbiducci, Fabrizio Ugo, Giorgio Marengo, Mario Iannaccone, Enrico Cerrato, Carlo di Mario, Claudio Moretti, Maurizio D'Amico, Ferdinando Varbella, Thomas F. Lüscher, Imad Sheiban, Javier Escaned, Francesco Romeo, Mauro Rinaldi, Gaetano Maria De Ferrari, Gerard Helft

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Incidence of Adverse Events at 3 Months Versus at 12 Months After Dual Antiplatelet Therapy Cessation in Patients Treated With Thin Stents With Unprotected Left Main or Coronary Bifurcations'. Together they form a unique fingerprint.

Medicine & Life Sciences